Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Relay Therapeutics (RLAY)
NASDAQ:RLAY
Relay Therapeutics (RLAY) Stock Price & Analysis
193 Followers
RLAY Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$12.65 - $35.36
Previous Close$15.31
Volume1.38M
Average Volume (3M)1.28M
Market Cap
$1.86B
Enterprise Value$917.23M
Total Cash (Recent Filing)$998.92M
Total Debt (Recent Filing)$57.74M
Price to Earnings (P/E)-5.9
Beta1.65
Next Earnings
May 04, 2023EPS Estimate
-$0.7Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.60
Shares Outstanding120,894,901
10 Day Avg. Volume1,003,465
30 Day Avg. Volume1,277,732
Standard Deviation0.19
R-Squared0.13
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)2.23
Price to Sales (P/S)1977.40
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-12.50
Enterprise Value/Market CapN/A
Enterprise Value/Revenue664.17
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-2.99
Forecast
1Y Price Target
$36.86Price Target Upside140.76% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering7
Relay Therapeutics News
RLAY FAQ
What was Relay Therapeutics’s price range in the past 12 months?
Relay Therapeutics lowest stock price was $12.65 and its highest was $35.36 in the past 12 months.
What is Relay Therapeutics’s market cap?
Currently, no data Available
When is Relay Therapeutics’s upcoming earnings report date?
Relay Therapeutics’s upcoming earnings report date is May 04, 2023 which is in 39 days.
How were Relay Therapeutics’s earnings last quarter?
Relay Therapeutics released its earnings results on Feb 23, 2023. The company reported -$0.56 earnings per share for the quarter, beating the consensus estimate of -$0.702 by $0.142.
Is Relay Therapeutics overvalued?
According to Wall Street analysts Relay Therapeutics’s price is currently Undervalued.
Does Relay Therapeutics pay dividends?
Relay Therapeutics does not currently pay dividends.
What is Relay Therapeutics’s EPS estimate?
Relay Therapeutics’s EPS estimate is -$0.7.
How many shares outstanding does Relay Therapeutics have?
Relay Therapeutics has 121,384,720 shares outstanding.
What happened to Relay Therapeutics’s price movement after its last earnings report?
Relay Therapeutics reported an EPS of -$0.56 in its last earnings report, beating expectations of -$0.702. Following the earnings report the stock price went down -2.123%.
Which hedge fund is a major shareholder of Relay Therapeutics?
Among the largest hedge funds holding Relay Therapeutics’s share is Perceptive Advisors LLC. It holds Relay Therapeutics’s shares valued at 29M.
---
Relay Therapeutics Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$36.86 (140.76% Upside)
$36.86 (140.76% Upside)
Blogger Sentiment
Bullish
RLAY Sentiment 100%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 2.1M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $108.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 0.6%
Last 30 Days ▲ 3.4%
Last 30 Days ▲ 3.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-49.01%
12-Months-Change
Fundamentals
Return on Equity
-31.44%
Trailing 12-Months
Asset Growth
9.06%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Relay Therapeutics
Relay Therapeutics Inc is a precision medicines company focused on enhancing small molecule therapeutic discovery in targeted oncology. Its pipeline products include RLY-1971 and RLY-4008 and among others.
---
Top 5 ETFs holding RLAY
Fidelity Nasdaq Composite Index ETF
$709.85K
Vanguard ESG U.S. Stock ETF
$239.07K
Invesco Nasdaq Biotechnology ETF
$25.71K
BMO MSCI Innovation Index ETF
$5.60K
V-Shares US Leadership Diversity ETF
$45.63
Up to five ETFs with an Outperform Smart Score that hold RLAY. The ETFs are listed according to market value of RLAY within the ETF
---
---